{"id":"https://openalex.org/W7225786197","doi":"https://doi.org/10.3389/fonc.2026.1892448","title":"HORIZON and LocoMMotion: a descriptive cross-study comparison of outcomes in triple-class refractory multiple myeloma","display_name":"HORIZON and LocoMMotion: a descriptive cross-study comparison of outcomes in triple-class refractory multiple myeloma","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225786197","doi":"https://doi.org/10.3389/fonc.2026.1892448"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1892448","doi":"https://doi.org/10.3389/fonc.2026.1892448","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1892448","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1892448/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1892448/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103890678","display_name":"Laura Pavan","orcid":"https://orcid.org/0009-0005-2218-7333","observed_orcids":["https://orcid.org/0009-0005-2218-7333"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Laura Pavan","raw_affiliation_strings":["Hematology Unit, Department of Medicine, University of Padova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Unit, Department of Medicine, University of Padova","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066814162","display_name":"Renato Zambello","orcid":"https://orcid.org/0000-0002-8799-5324","observed_orcids":["https://orcid.org/0000-0002-8799-5324"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Renato Zambello","raw_affiliation_strings":["Hematology Unit, Department of Medicine, University of Padova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Unit, Department of Medicine, University of Padova","institution_ids":["https://openalex.org/I138689650"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103890678"],"corresponding_institution_ids":["https://openalex.org/I138689650"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.840399980545044},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7745000123977661},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6151999831199646},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5595999956130981},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.5515000224113464},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5005000233650208},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49390000104904175},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.4083000123500824},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.4004000127315521},{"id":"https://openalex.org/C159176650","wikidata":"https://www.wikidata.org/wiki/Q43261","display_name":"Horizon","level":2,"score":0.3750999867916107},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33500000834465027},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3239000141620636},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3192000091075897},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.30869999527931213},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3061999976634979},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.3059999942779541},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2849000096321106},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2842999994754791},{"id":"https://openalex.org/C28761237","wikidata":"https://www.wikidata.org/wiki/Q7805321","display_name":"Time horizon","level":2,"score":0.28380000591278076},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.28040000796318054},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2782000005245209},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.26919999718666077},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.263700008392334},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.25290000438690186}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fonc.2026.1892448","doi":"https://doi.org/10.3389/fonc.2026.1892448","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1892448","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1892448/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1892448","doi":"https://doi.org/10.3389/fonc.2026.1892448","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1892448","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1892448/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225786197.pdf","grobid_xml":"https://content.openalex.org/works/W7225786197.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W2003734726","https://openalex.org/W2921533600","https://openalex.org/W2989630844","https://openalex.org/W3086255209","https://openalex.org/W3095960537","https://openalex.org/W3096205376","https://openalex.org/W3097896837","https://openalex.org/W3113262110","https://openalex.org/W3158482519","https://openalex.org/W4206012155","https://openalex.org/W4221027512","https://openalex.org/W4315754639","https://openalex.org/W4360806629","https://openalex.org/W4372311929","https://openalex.org/W4400094382","https://openalex.org/W4402852394","https://openalex.org/W4409258629","https://openalex.org/W4412037674","https://openalex.org/W4412070200"],"related_works":[],"abstract_inverted_index":{"Background":[0],"Multiple":[1],"myeloma":[2],"(MM)":[3],"is":[4],"a":[5,34,40,55,295],"relapsing":[6],"plasma":[7],"cell":[8,130,137],"malignancy.":[9],"Patients\u2019":[10],"refractory":[11],"to":[12,25,59,133],"proteasome":[13],"inhibitors,":[14],"immunomodulatory":[15],"drugs,":[16],"and":[17,33,63,84,98,116,141,178,192,198,211,219,232,239,258,274,288],"anti-CD38":[18],"antibodies":[19],"(triple-class":[20],"refractory)":[21],"and,":[22],"more":[23],"recently,":[24],"T-cell-redirected":[26],"(TCR)":[27],"therapies":[28],"have":[29],"limited":[30,222],"treatment":[31,302],"options":[32],"poor":[35],"prognosis.":[36],"Melphalan":[37],"flufenamide":[38],"(melflufen),":[39],"first-in-class":[41],"peptide\u2013drug":[42],"conjugate,":[43],"delivers":[44],"intracellular":[45],"alkylators":[46],"independently":[47],"of":[48,65,74,114,167,269,278],"prior":[49,124,127,151],"resistance":[50],"mechanisms.":[51],"Objective":[52],"This":[53,244],"was":[54,174,186,196,235],"descriptive":[56,245],"cross-study":[57,246],"comparison":[58,247],"indirectly":[60],"compare":[61],"efficacy":[62,293],"safety":[64,234],"melflufen":[66,255,299],"plus":[67,256],"dexamethasone":[68,257],"(HORIZON":[69],"trial)":[70],"versus":[71],"real-world":[72,259],"standard":[73],"care":[75],"(LocoMMotion":[76],"study)":[77],"in":[78,176,180,189,206,223,237,262,300],"relapsed/refractory":[79],"MM,":[80],"focusing":[81],"on":[82,251],"TCRMM":[83],"high-risk":[85,142,209],"subgroups.":[86,225],"Methods":[87],"Data":[88],"were":[89,203,217,229],"analyzed":[90],"from":[91],"the":[92,99,164,168,267,275,279],"single-arm,":[93],"phase":[94],"II":[95],"HORIZON":[96,145,177],"study":[97],"prospective,":[100],"observational":[101],"LocoMMotion":[102,155,280],"study.":[103],"Endpoints":[104],"included":[105],"overall":[106,111,171,194],"response":[107,172,215],"rate,":[108],"progression-free":[109],"survival,":[110,112],"duration":[113],"response,":[115],"treatment-emergent":[117],"adverse":[118,227],"events.":[119],"Subgroup":[120],"analyses":[121,166],"considered":[122,286],"\u22653":[123],"therapy":[125],"lines,":[126],"autologous":[128],"stem":[129,136],"transplant,":[131,138],"time":[132],"progression":[134,183],"post-autologous":[135],"extramedullary":[139,212],"disease,":[140,213],"cytogenetics.":[143],"Results":[144],"enrolled":[146],"157":[147],"patients":[148,157,207],"(median":[149,158],"5":[150],"lines;":[152,160],"76%":[153],"TCR),":[154],"248":[156],"4":[159],"74%":[161],"TCR).":[162],"In":[163],"initial":[165],"TCR":[169],"subgroups,":[170],"rate":[173],"26%":[175],"25.1%":[179],"LocoMMotion;":[181],"median":[182,193],"free":[184],"survival":[185,195,220],"3.9":[187],"months":[188],"both":[190],"studies,":[191],"11.2":[197],"11.1":[199],"months,":[200],"respectively.":[201],"Responses":[202],"also":[204],"observed":[205],"with":[208,254],"cytogenetics":[210],"but":[214],"rates":[216],"low":[218],"remained":[221],"these":[224,282],"Treatment-emergent":[226],"events":[228],"mostly":[230],"hematologic":[231],"manageable;":[233],"consistent":[236],"elderly":[238],"heavily":[240,263],"pretreated":[241,264],"patients.":[242],"Conclusion":[243],"provides":[248],"contextual":[249],"information":[250],"outcomes":[252],"reported":[253],"standard-of-care":[260],"regimens":[261],"TCRMM.":[265],"Given":[266],"absence":[268],"adjustment":[270],"for":[271,298],"baseline":[272],"differences":[273],"historical":[276],"nature":[277],"comparator,":[281],"findings":[283],"should":[284],"be":[285],"hypothesis-generating":[287],"do":[289],"not":[290],"establish":[291],"comparative":[292],"or":[294],"specific":[296],"role":[297],"contemporary":[301],"sequencing.":[303]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}